Supplementary Figure S4 from EZH2 Inhibitors Sensitize Breast Cancer to HER2 Kinase Inhibitors through Cooperative Effects on YAP and Proapoptotic Regulators
Fields of Study & Subjects
HER2/EGFR in Cancer Research
Hippo pathway signaling and YAP/TAZ
Epigenetics and DNA Methylation
Publication details
- Publication date
- 16 March 2026
- Language
- EN